
|
BioTime has formed a new science and technology committee to oversee the development and commercialization of its regenerative medicine and oncology tech. Newly appointed director and former US FDA commissioner Andrew von Eschenbach joins the three-member committee alongside Optimer Pharmaceuticals CEO Pedro Lichtinger, and Neal Bradsher who is president of Broadwood Capital. “The committee looks forward to working with the management of BioTime and its subsidiaries in advancing breakthrough products into clinical trials, including those anticipated to begin this year for the use of HyStem-Rx as an implantable matrix for cell delivery in cosmetic and reconstructive surgeries,” said von Eschenbach. Alfred Kingsley, BioTime chairman, added: “This is an exciting time for the emerging field of regenerative medicine.” |
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, in a...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has...
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.
In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, including news...
in-Pharmatechnologist.com looks back at the biggest stories of 2012.
in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics...